Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Natural killer and CD8+ T cells play a key role in hair loss in androgenetic alopecia.

γδ T cells help control tissue scarring and blood vessel growth in response to foreign objects.

The postnatal thymus has cells like mesenchymal stem cells that can become different cell types and help maintain thymus structure.

A method was created in 2005 to identify minoxidil, a hair growth ingredient, in products using two types of capillary zone electrophoresis, and it found that most products had about 2% minoxidil.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

A new classification for trichothiodystrophy helps identify genetic causes and potential treatments.

Telocytes, cells with long extensions, are vital for hair growth because they produce Wnt signals, which are necessary for hair follicle regeneration.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

Increasing regulatory T cells may help treat alopecia areata by reducing autoimmunity and promoting hair growth.

TSC22D genes are key in metabolic diseases and cancer, offering potential as treatment targets.

Defective T cell metabolism can cause early skin aging and poor hair follicle stem cell function.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Trichothiodystrophy hair is structurally abnormal with protein and organization issues.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

TLR4 is important in aging-related diseases and could be a new treatment target.

An automated system can predict death risk in thin melanoma by analyzing immune cells.

Trichoepitheliomas and some basal cell carcinomas likely come from hair follicle stem cells.

Skin cells control immune cell placement, helping the skin respond better to challenges.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

Using Mahua cake significantly boosts Bhringraj growth in agroforestry.

The higher dose supplement was more effective in treating female hair loss.

Three different methods were compared for creating Titan cells, a type of fungus cell. The OZ method made the most cells initially, but the number dropped quickly. The EB method also made a lot of cells, but the number also dropped. The AA method made fewer cells, but the number stayed steady. The methods also affected which genes were active in the cells.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Phosphodiesterase inhibitors like tadalafil can reduce cell growth in BPH caused by CD8+ T cells in low androgen conditions.